Leukemia, Myelomonocytic, Juvenile - 25 Studies Found
Recruiting |
: Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation :
|
Active, not recruiting |
: Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies :
|
Recruiting |
: Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies :
|
Completed |
: Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors :
|
Recruiting |
: Myeloproliferative Neoplasms (MPNs) Patient Registry :
|
Withdrawn |
: Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) :
|
Withdrawn |
: Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias :
|
Recruiting |
: CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant :
|
Terminated |
: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant :
|